CytoSorbents Corp. (CTSO)
0.46
-0.01
(-2.09%)
USD |
NASDAQ |
May 21, 16:00
0.435
-0.02
(-5.43%)
After-Hours: 19:59
CytoSorbents Research and Development Expense (TTM) : 4.448M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Delcath Systems, Inc. | 34.06M |
| Quest Diagnostics, Inc. | -- |
| Danaher Corp. | 1.606B |
| NovelStem International Corp. | -- |
| Illumina, Inc. | 949.00M |